Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/05/2012WO2011135303A3 Ubiquitination modulators
04/05/2012WO2011133966A3 Method and compositions for treating ace2-related disorders
04/05/2012WO2011133929A3 Reducing transmission of sexually transmitted infections
04/05/2012WO2011133893A3 Cyanide antidotes
04/05/2012WO2011133867A3 Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
04/05/2012WO2011133841A3 Intravenous omega-3 fatty acid compositions & method of use
04/05/2012WO2011133722A3 Anti-viral compounds
04/05/2012WO2011133719A3 Anti-viral compounds
04/05/2012WO2011130317A3 Therapeutic agents having reduced toxicity
04/05/2012WO2011127164A3 Pharmaceutical compositions to treat fibrosis
04/05/2012WO2011126733A3 Combination therapies: inhibitors of gaba transaminase and nkcc1
04/05/2012WO2011121418A9 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
04/05/2012WO2011119119A3 The combination of antifungal compound and modifier of proton homeostasis for destroying or growth inhibition and reproduction of fungi
04/05/2012WO2011116392A3 Use of p2x purinergic receptor agonists to enhance insulin secretion in pancreatic beta cells
04/05/2012WO2011116152A3 Delivery of agents using interfering nanoparticles
04/05/2012WO2011113036A3 Compositions and methods for expanding bfu-e cells
04/05/2012WO2011107281A3 Antimicrobial oil-in-water emulsion containing quaternary ammonium compounds
04/05/2012WO2011084638A3 Mesalamine suppository
04/05/2012WO2011068404A3 Administration of n-(3-ethynylphenylamino)-6,7-bis(2- methoxyethoxy)-4-quinazolinamine mesylate salt by inhalation
04/05/2012WO2011041713A3 Piperazinyl antiviral agents
04/05/2012WO2011032050A3 Gyrase inhibitors
04/05/2012WO2011011882A8 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
04/05/2012US20120084873 Sex-determination and methods of specifying same
04/05/2012US20120084871 Npc1l1 orthologues
04/05/2012US20120083602 Benzamides and related inhibitors of factor xa
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120083536 Antimicrobial adhesive system
04/05/2012US20120083535 Adhesive mixture for transdermal delivery of highly plasticizing drugs
04/05/2012US20120083534 Ophthalmic and contact lens solution
04/05/2012US20120083533 Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases
04/05/2012US20120083532 Novel uses
04/05/2012US20120083531 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
04/05/2012US20120083530 Thermally Stable Oil-in-Water Emulsions Containing an Oil That Contains Polyunsaturated Fatty Acids
04/05/2012US20120083529 Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
04/05/2012US20120083528 Novel protein kinase modulators and therapeutic uses thereof
04/05/2012US20120083527 Anticancer Agents
04/05/2012US20120083526 Synthesis of 1-(2,3-dihydrobenzofuran-4-yl)ethanone as intermediate in the preparation of ramelteon
04/05/2012US20120083525 Composition for preventing or treating obesity-related diseases mediated by the activation of ampk and including 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignans as active ingredients
04/05/2012US20120083524 Oral Composition Comprising DHA and Genistein for Enhancing Skin Properties
04/05/2012US20120083523 Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species
04/05/2012US20120083522 Modulation of inflammatory responses by factor xi
04/05/2012US20120083521 Aptamers as agonists
04/05/2012US20120083520 Ghrelin binding nucleic acids
04/05/2012US20120083519 Methods For Diagnosing And Treating A Renal Disease In An Individual
04/05/2012US20120083518 Cancer Treatment Targeting BRCA1-IRIS
04/05/2012US20120083517 Polymorphs of saxagliptin hydrochloride and processes for preparing them
04/05/2012US20120083516 Nasal sinus spray for treatment of sinus headache and method of using same
04/05/2012US20120083515 Bioadhesive gel based on hydroxyethylcellulose
04/05/2012US20120083514 Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
04/05/2012US20120083513 3-Substituted-8-Substituted-3H-Imidazo[5,1-d][1,2,3,5]tetrazin-4-one Compounds and Their Use
04/05/2012US20120083512 Pharmaceutical product for injection
04/05/2012US20120083511 Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol
04/05/2012US20120083510 Perfluorocarbons for use in treating pruritus
04/05/2012US20120083508 Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain
04/05/2012US20120083507 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
04/05/2012US20120083506 Reduction of opioid blood fluctuations
04/05/2012US20120083505 Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
04/05/2012US20120083504 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof
04/05/2012US20120083503 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer
04/05/2012US20120083502 Heterocyclic compounds and their uses
04/05/2012US20120083501 Compounds for treating neurodegenerative diseases
04/05/2012US20120083500 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x 2/3 antagonists
04/05/2012US20120083499 Novel benzenesulfonamides as calcium channel blockers
04/05/2012US20120083498 Modulators of Viral Transcription, and Methods and Compositions Therewith
04/05/2012US20120083496 Isoxazole compound for the treatment of cancer
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
04/05/2012US20120083493 Small-molecule modulators of trp-p8 activity
04/05/2012US20120083492 Imidazopyrazines for use as kinase inhibitors
04/05/2012US20120083490 Cytochrome p450 oxidase inhibitors and uses thereof
04/05/2012US20120083489 Bis-pyridylpyridones as melanin-concentrating hormone receptor antagonists
04/05/2012US20120083488 Tetracyclic compound
04/05/2012US20120083487 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
04/05/2012US20120083486 Kit, composition, product or medicament for treating cognitive impairment
04/05/2012US20120083485 Noribogaine in the treatment of pain and drug addiction
04/05/2012US20120083484 Cyclopamine lactam analogs and methods of use thereof
04/05/2012US20120083483 Inhibitors of hepatitis c virus replication
04/05/2012US20120083482 Inhibitors of vegf receptor and hgf receptor signaling
04/05/2012US20120083481 Formulations of deoxycholic acid and salts thereof
04/05/2012US20120083480 Controlled release delivery system for nasal applications
04/05/2012US20120083479 Compositions Comprising Azelastine and Methods of Use Thereof
04/05/2012US20120083478 Crystalline oxalate salts of a diamide compound
04/05/2012US20120083477 Proteasome inhibitors and uses thereof
04/05/2012US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
04/05/2012US20120083475 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
04/05/2012US20120083474 Heterocyclic amides as modulators of trpa1
04/05/2012US20120083473 Treatment of conditions by toll-like receptor modulators
04/05/2012US20120083472 Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients
04/05/2012US20120083471 Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same
04/05/2012US20120083470 Inhibitors of tyrosine kinases and uses thereof
04/05/2012US20120083469 Inhibitors of arginase and their therapeutic applications
04/05/2012US20120083468 Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
04/05/2012US20120083466 Lipid conjugates in the treatment of allergic rhinitis
04/05/2012US20120083465 Method for blocking ligation of the receptor for advanced glycation end-products (rage)
04/05/2012US20120083464 Neuroprotective properties of 5'-methylthioadenosine
04/05/2012US20120083462 Pharmaceutical anti-infective composition for inhalation
04/05/2012US20120083461 Agent for inhibiting peritoneal membrane thickening
04/05/2012US20120083460 Readily water-soluble isoquercitrin composition
04/05/2012US20120083459 Use of ganglioside to decrease propagation of malignant prostate cells
04/05/2012US20120083447 Novel Therapeutic Treatments Using Centhaquin
1 ... 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 ... 7860